Oncology Pharma (OTCMKTS:ONPH) versus Global-E Online (NASDAQ:GLBE) Financial Comparison

Global-E Online (NASDAQ:GLBE) and Oncology Pharma (OTCMKTS:ONPH) are both retail/wholesale companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Insider & Institutional Ownership

94.6% of Global-E Online shares are held by institutional investors. 11.6% of Global-E Online shares are held by insiders. Comparatively, 18.0% of Oncology Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Global-E Online and Oncology Pharma”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global-E Online	$752.76 million	9.29	-$133.80 million	($0.44)	-96.80
Oncology Pharma	N/A	N/A	N/A	N/A	N/A

Oncology Pharma has lower revenue, but higher earnings than Global-E Online.

Volatility and Risk

Global-E Online has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, Oncology Pharma has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for Global-E Online and Oncology Pharma, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global-E Online	0	1	11	0	2.92
Oncology Pharma	0	0	0	0	0.00

Global-E Online currently has a consensus target price of $59.58, suggesting a potential upside of 39.90%. Given Global-E Online’s stronger consensus rating and higher possible upside, research analysts clearly believe Global-E Online is more favorable than Oncology Pharma.

Profitability

This table compares Global-E Online and Oncology Pharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global-E Online	-10.04%	-8.56%	-6.47%
Oncology Pharma	N/A	N/A	N/A

Summary

Global-E Online beats Oncology Pharma on 6 of the 10 factors compared between the two stocks.

About Global-E Online

Global-E Online Ltd., together with its subsidiaries, provides a platform to enable and accelerate direct-to-consumer cross-border e-commerce in Israel, the United Kingdom, the United States, and internationally. Its platform enables international shoppers to buy online and merchants to sell from, and to, worldwide. The company was incorporated in 2013 and is headquartered in Petah Tikva, Israel.

About Oncology Pharma

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.